Article

How Will Costs be Addressed

The panel members discuss the question of how much would it cost to abolish the SGR.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Dr Elise Tremblay
Dr Elise Tremblay
Related Content
Drug costs in US | Image Credit: Kenishirotie - stock.adobe.com
August 24th 2025

Patent Extensions Cost US $3.5 Billion in Delayed Generic Savings

Pearl Steinzor
The Center for Biosimilars podcast banner
August 24th 2025

Follow the Science: Bridging the Biosimilar Gap With Dr Hillel Cohen

Skylar Jeremias Hillel P. Cohen, PhD Giuseppe Randazzo
GLP-1 medications and payer benefits | Image credit: zimmytws - stock.adobe.com
August 24th 2025

Building Accountability Into GLP-1 Benefit Design: Lessons From Delaware and Philadelphia

Skylar Jeremias
managed care cast logo
August 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
PACE participants | Image: National PACE Association
August 24th 2025

PACE Program Expansion Requires For-Profit Investment, Reduced Regulatory Burden, and Greater Patient Eligibility

Wayne Winegarden, PhD
AJMC
August 24th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo